Genetic Technologies Ltd (GENE) — Financial Flexibility Index
Genetic Technologies Ltd (GENE) has a Financial Flexibility Index of -1.30x as of June 2024. Free cash flow of $-5.66 Million (operating CF $-5.67 Million minus capex $4.73K) represents -1% of total liabilities ($4.36 Million). Check GENE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genetic Technologies Ltd Financial Flexibility Index (2000–2024)
Historical Financial Flexibility Index trend for Genetic Technologies Ltd across 25 annual periods. For the full cash flow conversion analysis, see Genetic Technologies Ltd cash conversion from operations.
Annual Financial Flexibility Index for Genetic Technologies Ltd (2000–2024)
Year-by-year free cash flow to debt coverage for Genetic Technologies Ltd. Explore Genetic Technologies Ltd (GENE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.21x | $-9.65 Million | $-9.68 Million | $4.36 Million | ▲ +15.7% |
| 2023 | -2.63x | $-9.71 Million | $-9.72 Million | $3.69 Million | ▼ -106.5% |
| 2022 | -1.27x | $-5.56 Million | $-5.66 Million | $4.37 Million | ▲ +67.6% |
| 2021 | -3.93x | $-5.65 Million | $-6.30 Million | $1.44 Million | ▼ -13.6% |
| 2020 | -3.46x | $-5.67 Million | $-5.71 Million | $1.64 Million | ▲ +14.2% |
| 2019 | -4.03x | $-6.02 Million | $-6.07 Million | $1.49 Million | ▼ -4.1% |
| 2018 | -3.87x | $-5.63 Million | $-5.64 Million | $1.45 Million | ▲ +9.9% |
| 2017 | -4.30x | $-6.58 Million | $-6.81 Million | $1.53 Million | ▲ +18.5% |
| 2016 | -5.28x | $-7.42 Million | $-7.73 Million | $1.41 Million | ▲ +2.2% |
| 2015 | -5.40x | $-9.50 Million | $-9.69 Million | $1.76 Million | ▼ -141.8% |
| 2014 | -2.23x | $-10.94 Million | $-10.99 Million | $4.90 Million | ▲ +23.4% |
| 2013 | -2.91x | $-7.46 Million | $-7.52 Million | $2.56 Million | ▲ +21.8% |
| 2012 | -3.73x | $-7.60 Million | $-7.67 Million | $2.04 Million | ▼ -431.1% |
| 2011 | 1.13x | $2.37 Million | $2.23 Million | $2.11 Million | ▲ +173.6% |
| 2010 | -1.53x | $-3.92 Million | $-4.30 Million | $2.56 Million | ▼ -25.4% |
| 2009 | -1.22x | $-5.84 Million | $-6.10 Million | $4.79 Million | ▼ -845.7% |
| 2008 | 0.16x | $541.94K | $423.68K | $3.32 Million | ▼ -71.9% |
| 2007 | 0.58x | $2.36 Million | $2.20 Million | $4.05 Million | ▲ +140.8% |
| 2006 | -1.43x | $-5.96 Million | $-6.13 Million | $4.18 Million | ▼ -55.8% |
| 2005 | -0.92x | $-5.97 Million | $-6.58 Million | $6.51 Million | ▼ -35.2% |
| 2004 | -0.68x | $-3.61 Million | $-4.52 Million | $5.32 Million | ▼ -153.7% |
| 2003 | -0.27x | $-792.74K | $-993.71K | $2.97 Million | ▲ +84.1% |
| 2002 | -1.68x | $-3.13 Million | $-3.32 Million | $1.86 Million | ▼ -29.6% |
| 2001 | -1.29x | $-2.10 Million | $-2.23 Million | $1.62 Million | ▼ -419.2% |
| 2000 | -0.25x | $-316.68K | $-318.68K | $1.27 Million | — |